Literature DB >> 11370672

Melittin exerts multiple effects on the release of free fatty acids from L1210 cells: lack of selective activation of phospholipase A2 by melittin.

S Y Lee1, H S Park, S J Lee, M U Choi.   

Abstract

Melittin is known as a phospholipase A2 (PLA2) activator, but the selectivity of its effect on PLA2 is uncertain. We examined the selectivity of melittin effect on the release of free fatty acids (FFAs) from L1210 cells using various inhibitors. A systemic lipid analysis by HPLC and GLC revealed that melittin induced release of various FFAs including saturated, monounsaturated, and polyunsaturated FFAs. Various PLA2 inhibitors examined exerted only minimal effects on the melittin-induced arachidonic acid (AA) and palmitic acid (PAL) releases. Specific inhibitors of phosphatidylinositol-phospholipase C (U73122) and diacylglycerol lipase (RHC80267) exerted significant inhibitory effects on both AA and PAL releases. These results suggest that melittin-induced FFA release is most likely due to multiple participations of various types of lipases. Since BAPTA/AM, an intracellular Ca2+ chelator, did not influence the FFA release, the Ca2+ influxed by melittin appeared not to be a key factor for the FFA release. The mimicking of the melittin-induced FFA release by digitonin, a membrane-permeabilizing agent, implies that the membrane-perturbing action of melittin is likely the cause of the FFA release. Melittin also induced release of multiple FFAs from other cell lines including P388D1 and HL60. The rapid melittin-stimulated phospholipase D (PLD) observed in L1210 cells appeared not directly related to the steady release of FFA, as indicated by the fact that the PLD was not blocked by RHC80267. In view of melittin's multiple effects on the composition of cellular lipids, we conclude that melittin does neither exclusively release any single FFA nor selectively activate PLA2 in L1210 cells. The problem of using melittin as a PLA2 activator is discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11370672     DOI: 10.1006/abbi.2001.2314

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  7 in total

1.  Melittin initiates dopamine transporter internalization and recycling in transfected HEK-293 cells.

Authors:  Dove J Keith; Katherine Wolfrum; Amy J Eshleman; Aaron Janowsky
Journal:  Eur J Pharmacol       Date:  2012-06-05       Impact factor: 4.432

2.  Melittin modulates keratinocyte function through P2 receptor-dependent ADAM activation.

Authors:  Anselm Sommer; Anja Fries; Isabell Cornelsen; Nancy Speck; Friedrich Koch-Nolte; Gerald Gimpl; Jörg Andrä; Sucharit Bhakdi; Karina Reiss
Journal:  J Biol Chem       Date:  2012-05-21       Impact factor: 5.157

3.  Melittin stimulates fatty acid release through non-phospholipase-mediated mechanisms and interacts with the dopamine transporter and other membrane-spanning proteins.

Authors:  Dove J Keith; Amy J Eshleman; Aaron Janowsky
Journal:  Eur J Pharmacol       Date:  2010-10-20       Impact factor: 4.432

4.  Regulation of activity in vitro and in vivo of three phospholipases B from Saccharomyces cerevisiae.

Authors:  Olaf Merkel; Olga V Oskolkova; Florian Raab; Rosemarie El-Toukhy; Fritz Paltauf
Journal:  Biochem J       Date:  2005-04-15       Impact factor: 3.857

Review 5.  Glucocorticoids shift arachidonic acid metabolism toward endocannabinoid synthesis: a non-genomic anti-inflammatory switch.

Authors:  Renato Malcher-Lopes; Alier Franco; Jeffrey G Tasker
Journal:  Eur J Pharmacol       Date:  2008-01-31       Impact factor: 4.432

6.  Effect of Melittin on Metabolomic Profile and Cytokine Production in PMA-Differentiated THP-1 Cells.

Authors:  Abdulmalik M Alqarni; Valerie A Ferro; John A Parkinson; Mark J Dufton; David G Watson
Journal:  Vaccines (Basel)       Date:  2018-10-13

7.  The Influence of Bee Venom Melittin on the Functioning of the Immune System and the Contractile Activity of the Insect Heart-A Preliminary Study.

Authors:  Jan Lubawy; Arkadiusz Urbański; Lucyna Mrówczyńska; Eliza Matuszewska; Agata Światły-Błaszkiewicz; Jan Matysiak; Grzegorz Rosiński
Journal:  Toxins (Basel)       Date:  2019-08-27       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.